Windward Bio Raises $225 Million in Nasdaq IPO at $1.69 Billion Valuation
Windward Bio priced its Nasdaq IPO at $17 per share, raising $225 million with a $50 million Sanofi placement, and closed day one valued at $1.69 billion.
Topic
Topic
Windward Bio priced its Nasdaq IPO at $17 per share, raising $225 million with a $50 million Sanofi placement, and closed day one valued at $1.69 billion.